Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Bunting

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Biochemistry|September 17, 2004
Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?Peter S Bunting
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 1, 2001
Screening for prostate cancer with prostate-specific antigen: beware the biasesPeter S Bunting
Clinical Chemistry|December 20, 2003
Effect of a controlled feedback intervention on laboratory test ordering by community physiciansPeter S Bunting, Carl Van Walraven
Clinical Biochemistry|January 30, 2008
Mass colorectal cancer screening: methodological quality of practice guidelines is not related to their content validityJoseph C Watine, Peter S Bunting
The Canadian Journal of Urology|February 19, 2009
Reliability of self-report versus chart-based prostate cancer, PSA, DRE and urinary symptomsEric C Sayre, Peter S Bunting, Jacek A Kopec
Clinical Biochemistry|November 5, 2002
Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observationPeter S Bunting, Gerrit DeBoer, Richard Choo, et al.
Journal of Clinical Epidemiology|May 10, 2005
A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control studyPeter S Bunting, Jan Neuman, Vivek Goel, et al.
Clinical Chemistry|January 5, 2006
Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitionersJoseph Watine, Bruno Friedberg, Eva Nagy, et al.
The Journal of Urology|July 12, 2005
Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control studyJacek A Kopec, Vivek Goel, Peter S Bunting, et al.
Critical Care Medicine|December 15, 2005
Reliability of point-of-care testing for glucose measurement in critically ill adultsSalmaan Kanji, Jennifer Buffie, Brian Hutton, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Biochemistry|September 17, 2004
Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?Peter S Bunting
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 1, 2001
Screening for prostate cancer with prostate-specific antigen: beware the biasesPeter S Bunting
Clinical Chemistry|December 20, 2003
Effect of a controlled feedback intervention on laboratory test ordering by community physiciansPeter S Bunting, Carl Van Walraven
Clinical Biochemistry|January 30, 2008
Mass colorectal cancer screening: methodological quality of practice guidelines is not related to their content validityJoseph C Watine, Peter S Bunting
The Canadian Journal of Urology|February 19, 2009
Reliability of self-report versus chart-based prostate cancer, PSA, DRE and urinary symptomsEric C Sayre, Peter S Bunting, Jacek A Kopec
Clinical Biochemistry|November 5, 2002
Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observationPeter S Bunting, Gerrit DeBoer, Richard Choo, et al.
Journal of Clinical Epidemiology|May 10, 2005
A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control studyPeter S Bunting, Jan Neuman, Vivek Goel, et al.
Clinical Chemistry|January 5, 2006
Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitionersJoseph Watine, Bruno Friedberg, Eva Nagy, et al.
The Journal of Urology|July 12, 2005
Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control studyJacek A Kopec, Vivek Goel, Peter S Bunting, et al.
Critical Care Medicine|December 15, 2005
Reliability of point-of-care testing for glucose measurement in critically ill adultsSalmaan Kanji, Jennifer Buffie, Brian Hutton, et al.
Pageof 2